Uppsala, Sweden, November 12th, 2007
Beactica AB announced today that it has entered into a drug discovery collaboration agreement with Arrow Therapeutics Ltd (London, UK) whereby Beactica will direct its novel characterisation technology at selected Arrow compounds against a confidential target.
"We are... [...]
Uppsala, Sweden, November 1st, 2007
Beactica, the specialist drug discovery company spun out of Uppsala University in 2006, announced today that it has moved into new premises at the Uppsala Biomedical Centre.
"The move reflects a growing demand for Beactica’s partnership programme from other drug discovery... [...]
Uppsala, Sweden – September 14th, 2007
Beactica, the specialist drug discovery company spun out of Uppsala University in 2006, will partner in two separate projects both of which have been selected for major grants through the 7th EU Framework Programme. In each project Beactica will apply its drug discovery platform... [...]
Sweden, June 7, 2007
Beactica receives continued funding from Innovationsbron Uppsala to develop its business. [...]
Sweden, April 2, 2007
Beactica receives funding from the Swedish Governmental Agency for Innovation Systems (VINNOVA) to establish a European drug discovery project. [...]
Sweden, November 22, 2006
Beactica receives funding from ALMI Företagspartner to develop its technology platform. [...]
Sweden, October 8, 2006
Beactica wins business competition organised by the Swedish Governmental Agency for Innovation Systems (VINNOVA) and receives funding. [...]
Uppsala, Sweden, October 5, 2006
Beactica receives funding from Innovationsbron Uppsala to develop its technology platform. [...]
Uppsala, Sweden, September 19th, 2006
Beactica receives funding from Uppsala University Holding Company to develop its technology platform. [...]
Uppsala, Sweden, August 25th, 2006
Beactica is founded in Uppsala by Dr Per Källblad, previously at Medivir AB, and Professor Helena Danielson at Uppsala University. [...]